Stay updated with breaking news from Performance Enzymes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) saw a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 2,520,000 shares, an increase of 7.2% from the September 30th total of 2,350,000 shares. Based on an average daily trading volume, of 1,020,000 shares, the short-interest ratio […]
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 2,520,000 shares, an increase of 7.2% from the September 30th total of 2,350,000 shares. Based on an average daily trading volume, of 1,020,000 shares, […]
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price among […]
StockNews.com lowered shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a report published on Thursday. A number of other analysts also recently issued reports on CDXS. TD Cowen downgraded shares of Codexis from an outperform rating to a market perform rating and reduced their price target for […]
StockNews.com cut shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a research report sent to investors on Thursday. CDXS has been the subject of several other reports. Stifel Nicolaus reduced their price objective on Codexis from $9.00 to $5.00 and set a buy rating for the company […]